Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease
Postmarketing surveillance study update for Atrovent Inhalets in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
A postmarketing surveillance study of Atrovent for chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease
A postmarketing surveillance study evaluating Atrovent Inhalets for chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease
This document summarizes a postmarketing surveillance study of Atrovent Inhalation Solution in COPD. The study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease
This document reports a completed postmarketing surveillance study of Atrovent Inhaletten for chronic obstructive pulmonary disease, sponsor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Evaluating the Effect of Oxygentherapy on Concentration at Chronic Lung Patients [NA]
The clinical trial NCT02125916 evaluating oxygen therapy in patients with chronic lung diseases has completed. No results are provided in th…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Postmarketing Surveillance Study of Atrovent® in Chronic Obstructive Airways Disease
This document reports the completion of a postmarketing surveillance study of Atrovent for chronic obstructive pulmonary disease. It summari…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 trial completed evaluating the comparability of ipratropium bromide HFA-134a inhalation aerosol to Atrovent CFC inhalation aerosol i…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032) [Phase 1]
Phase 1 trial update on the effects of suvorexant in patients with chronic obstructive pulmonary disease (MK-4305-032) completed with result…
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Post-marketing Surveillance of Ventilat® Metered Dose Inhaler in Chronic Obstructive Bronchitis
A completed post-marketing surveillance study evaluating the Ventilat inhaler in chronic obstructive pulmonary disease reports safety data c…
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
Post-marketing surveillance update summarizing safety observations for Atrovent in chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease
This document reports the completion of a post-marketing surveillance study evaluating the safety profile of Atrovent Inhalers in chronic ob…
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Asymptomatic Versus Symptomatic Mild COPD: Comparisons at Rest and at Exercise [NA]
This update describes a completed clinical trial comparing asymptomatic and symptomatic mild chronic obstructive pulmonary disease patients …
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease
Reported results from a long-term post-marketing surveillance study evaluating Ventilat® in the treatment of chronic obstructive pulmonary d…
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Voriconazole for IPA in Chinese Patients With COPD [Phase 4]
A Phase 4 clinical trial evaluating voriconazole for invasive pulmonary aspergillosis in Chinese patients with COPD; the trial status is cur…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese Subjects [Phase 4]
A Phase 4 crossover trial evaluated the combination of ADOAIR twice daily plus tiotropium once daily against each monotherapy in Japanese pa…
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease
This completed postmarketing surveillance trial evaluated the safety profile of the Berodual inhaler (ipratropium bromide and fenoterol) in …
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Co-administration of Olodaterol Respimat® and Tiotropium Handihaler® [Phase 3]
A Phase 3 trial evaluating the co-administration of olodaterol (Striverdi Respimat) and tiotropium (Spiriva HandiHaler) in chronic obstructi…
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease
Completed clinical trial evaluating Berodual Respimat inhalation solution in patients with Chronic Obstructive Pulmonary Disease.
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Airways Disease
A completed postmarketing surveillance study of Berodual MDI in chronic obstructive pulmonary disease sponsored by Boehringer Ingelheim.
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Post-marketing Surveillance of Berodual® Metered-dose Inhaler in the Treatment of Chronic Obstructive Respiratory Tract Disease
A completed post-marketing surveillance study of Berodual metered-dose inhaler in chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease
This postmarketing surveillance study assessed handling and patient satisfaction with Berodual Respimat inhalation solution in people with c…
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease
Clinical trial update noting the completion of a study evaluating Berodual Respimat inhalation solution in chronic obstructive pulmonary dis…
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: Chronic Obstructive Pulmonary Disease Markers and Prognosis
This clinical trial studying markers and prognosis in chronic obstructive pulmonary disease has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Phase 4 trial evaluating whether adding Symbicort to Spiriva improves efficacy and tolerability versus Spiriva alone in patients with severe…